IDH WILDTYPE GLIOBLASTOMA
Clinical trials for IDH WILDTYPE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH WILDTYPE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for IDH WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive brain cancer? early trial of ERAS-801 begins
Disease control Recruiting nowThis early-phase trial tests the safety of a drug called ERAS-801 in 10 adults with recurrent glioblastoma, a fast-growing brain cancer. The drug targets a protein called EGFR that is overactive in many of these tumors. Researchers will also check if the drug affects tumor activi…
Matched conditions: IDH WILDTYPE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could the time you take chemo make a difference? new trial investigates
Symptom relief Recruiting nowThis pilot study looks at whether taking the chemotherapy drug temozolomide at a specific time of day (morning or evening) is practical for people with glioblastoma, a type of brain cancer. Fifty adults who have completed surgery and radiation will be randomly assigned to take th…
Matched conditions: IDH WILDTYPE GLIOBLASTOMA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC